118 related articles for article (PubMed ID: 31938951)
1. Association between lifestyle, dietary, reproductive, and anthropometric factors and circulating 27-hydroxycholesterol in EPIC-Heidelberg.
Le Cornet C; Johnson TS; Lu DL; Kaaks R; Fortner RT
Cancer Causes Control; 2020 Feb; 31(2):181-192. PubMed ID: 31938951
[TBL] [Abstract][Full Text] [Related]
2. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT
J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454
[TBL] [Abstract][Full Text] [Related]
3. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.
Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT
Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687
[TBL] [Abstract][Full Text] [Related]
4. 27-Hydroxycholesterol, an Endogenous SERM, and Risk of Fracture in Postmenopausal Women: A Nested Case-Cohort Study in the Women's Health Initiative.
Chang PY; Feldman D; Stefanick ML; McDonnell DP; Thompson BM; McDonald JG; Lee JS
J Bone Miner Res; 2019 Jan; 34(1):59-66. PubMed ID: 30138538
[TBL] [Abstract][Full Text] [Related]
5. Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort.
Sarink D; Yang J; Johnson T; Chang-Claude J; Overvad K; Olsen A; Tjønneland A; Fournier A; Mancini FR; Kvaskoff M; Boeing H; Trichopoulou A; Karakatsani A; Valanou E; Agnoli C; Sacerdote C; Masala G; Mattiello A; Tumino R; Van Gils CH; Skeie G; Gram IT; Weiderpass E; Lujan-Barroso L; Petrova D; Santiuste C; Quirós JR; Barricarte A; Amiano P; Travis RC; Gunter M; Dossus L; Christakoudi S; Kaaks R; Fortner RT
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1746-1754. PubMed ID: 31292137
[TBL] [Abstract][Full Text] [Related]
6. Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case-control study of the Multiethnic Cohort Study.
DeRouen MC; Yang J; Li Y; Franke AA; Tome AN; White KK; Hernandez BY; Shvetsov Y; Setiawan V; Wu AH; Wilkens LR; Le Marchand L; Loo LWM; Cheng I
Breast Cancer Res; 2023 Aug; 25(1):95. PubMed ID: 37580793
[TBL] [Abstract][Full Text] [Related]
7. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of serum oxysterols and lanosterol among postmenopausal women: Results from EPIC-Heidelberg.
Lu DL; Sookthai D; Le Cornet C; Katzke VA; Johnson TS; Kaaks R; Fortner RT
Clin Biochem; 2018 Feb; 52():117-122. PubMed ID: 29108727
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.
Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ
Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467
[TBL] [Abstract][Full Text] [Related]
10. Food and nutrient intake, anthropometric measurements and smoking according to alcohol consumption in the EPIC Heidelberg study.
Ruf T; Nagel G; Altenburg HP; Miller AB; Thorand B
Ann Nutr Metab; 2005; 49(1):16-25. PubMed ID: 15735364
[TBL] [Abstract][Full Text] [Related]
11. Dietary Patterns and Plasma Sex Hormones, Prolactin, and Sex Hormone-Binding Globulin in Premenopausal Women.
Hirko KA; Spiegelman D; Barnett JB; Cho E; Willett WC; Hankinson SE; Eliassen AH
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):791-8. PubMed ID: 26980437
[TBL] [Abstract][Full Text] [Related]
12. The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women.
Bradbury KE; Balkwill A; Tipper SJ; Crowe FL; Reeves GK; Green J; Beral V; Key TJ;
Growth Horm IGF Res; 2015 Apr; 25(2):90-5. PubMed ID: 25641638
[TBL] [Abstract][Full Text] [Related]
13. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.
Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S
Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
Verkasalo PK; Thomas HV; Appleby PN; Davey GK; Key TJ
Cancer Causes Control; 2001 Jan; 12(1):47-59. PubMed ID: 11227925
[TBL] [Abstract][Full Text] [Related]
15. Dietary and lifestyle predictors of age at natural menopause and reproductive span in the Shanghai Women's Health Study.
Dorjgochoo T; Kallianpur A; Gao YT; Cai H; Yang G; Li H; Zheng W; Shu XO
Menopause; 2008; 15(5):924-33. PubMed ID: 18600186
[TBL] [Abstract][Full Text] [Related]
16. 27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.
He S; Nelson ER
Maturitas; 2017 Oct; 104():29-35. PubMed ID: 28923174
[TBL] [Abstract][Full Text] [Related]
17. Vegetable and fruit consumption associated with anthropometric, dietary and lifestyle factors in Spain. EPIC Group of Spain. European Prospective Investigation into Cancer.
Agudo A; Pera G
Public Health Nutr; 1999 Sep; 2(3):263-71. PubMed ID: 10512560
[TBL] [Abstract][Full Text] [Related]
18. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.
Umetani M; Domoto H; Gormley AK; Yuhanna IS; Cummins CL; Javitt NB; Korach KS; Shaul PW; Mangelsdorf DJ
Nat Med; 2007 Oct; 13(10):1185-92. PubMed ID: 17873880
[TBL] [Abstract][Full Text] [Related]
19. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.
DuSell CD; Nelson ER; Wang X; Abdo J; Mödder UI; Umetani M; Gesty-Palmer D; Javitt NB; Khosla S; McDonnell DP
Endocrinology; 2010 Aug; 151(8):3675-85. PubMed ID: 20501668
[TBL] [Abstract][Full Text] [Related]
20. The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.
McDonnell DP; Chang CY; Nelson ER
Climacteric; 2014 Dec; 17 Suppl 2(0 2):60-5. PubMed ID: 25320023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
